Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
International Journal of Molecular Sciences · 18.04.2023 · 24 (8) · 7454
DOI: 10.3390/ijms24087454 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2023. Verfasst von Muhammad Sohaib Khan und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang-si 10326, Republic of Korea. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hyperandrogenism, Insulin Resistance. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean government (MSIT).
Abstract (Originalsprache)
A significant fraction of couples around the world suffer from polycystic ovarian syndrome (PCOS), a disease defined by the characteristics of enhanced androgen synthesis in ovarian theca cells, hyperandrogenemia, and ovarian dysfunction in women. Most of the clinically observable symptoms and altered blood biomarker levels in the patients indicate metabolic dysregulation and adaptive changes as the key underlying mechanisms. Since the liver is the metabolic hub of the body and is involved in steroid-hormonal detoxification, pathological changes in the liver may contribute to female endocrine disruption, potentially through the liver-to-ovary axis. Of particular interest are hyperglycemic challenges and the consequent changes in liver-secretory protein(s) and insulin sensitivity affecting the maturation of ovarian follicles, potentially leading to female infertility. The purpose of this review is to provide insight into emerging metabolic mechanisms underlying PCOS as the primary culprit, which promote its incidence and aggravation. Additionally, this review aims to summarize medications and new potential therapeutic approaches for the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang-si 10326, Republic of Korea.
- Department of Obstetrics and Gynecology, Dongguk University Ilsan Medical Center, Goyang-si 10326, Republic of Korea.
- Department of Obstetrics and Gynecology, Dongguk University Medical College, Goyang-si 10326, Republic of Korea.
ORCID-Profile: Muhammad Sohaib Khan, Hee-Sun Kim
Förderung
- National Research Foundation of Korea
- Korean government (MSIT)
Zitieren
APA
Khan, M. S., Kim, H. S., Kim, R., Yoon, S. H., & Kim, S. G. (2023). Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences, 24(8), 7454. https://doi.org/10.3390/ijms24087454
Vancouver
Khan MS, Kim HS, Kim R, Yoon SH, Kim SG. Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. International Journal of Molecular Sciences. 2023;24(8):7454. doi:10.3390/ijms24087454
BibTeX
@article{Khan2023,
author = {Khan, Muhammad Sohaib and Kim, Hee-Sun and Kim, Ranhee and Yoon, Sang Ho and Kim, Sang Geon},
title = {Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7454},
doi = {10.3390/ijms24087454}
}
EUVIMED